GREENBERG LAB -- Lab Members

Lab Members

file

Philip Greenberg, MD

Member & Head, Program of Immunology, Clinical Research Division, Fred Hutch
Professor of Immunology and Medicine, University of Washington

Bio
Faculty Profile
Featured Researcher Profile


file

Daniel Egan, MD

Assistant Member, Principal Investigator, Clinical Trials

Faculty Profile

Dan works closely with the Greenberg team to design and manage clinical trials that result from laboratory advances.


file

Sylvia Lee, MD

Joint Assistant Member, Principal Investigator, Clinical Trials

Faculty Profile

Sylvia works closely with the Greenberg team to design and manage clinical trials that result from laboratory advances.


file

Thomas Schmitt, PhD

Research Associate


Tom is generating and optimizing expression vectors encoding high affinity WTI-specific TCR genes for use in T cell therapy trials. He is also developing novel methods for the directed evolution of tumor specific TCRs in vitro.


file

Ingunn Stromnes, PhD

Research Associate


Ingunn is investigating properties of target antigens and tumor microenvironments that influence the efficacy of adoptive T cell immunotherapy, using a spontaneous mouse model of pancreatic cancer. She is also testing means to abrogate negative regulators tumor-reactive T cells to improve the efficacy of adoptive immunotherapies for cancers and persistent viral infections.


file

Rachel Perret, PhD

Postdoctoral Research Fellow


Rachel is expanding the cloned, high affinity, WT1-specific TCR repertoire to include several different HLA specificities as well as developing TCRs specific for the cancer testes antigen, cyclin A1. She is using bioinformatics screens, in vitro cell line testing and in vivo toxicity studies in HLA-transgenic mice to select optimal TCRs to translate into T cell therapy clinical trials for the treatment of pediatric and adult AML, as well as other cancers.


file

Luca Castelli, PhD

Staff Scientist


Luca recently joined the lab after working as a Senior Scientist at Emergent BioSolutions. He has special expertise in bi-specific protein therapeutics, state-of-the-art flow cytometry and developing assays that can be used to measure immune responses and identify opportunities for optimization.


file

Kristin Anderson, PhD

Research Associate


Kristin studies properties of T cell migration and tumor microenvironments that impact the utility of adoptive T cell therapy for ovarian cancer. Chemotherapy, immune checkpoint blockade and abrogation of other negative T cell regulators and select cell depletion techniques are being tested as strategies that might enhance immunotherapy efficacy. 


file

Shannon Oda, PhD

Postdoctoral Research Fellow


Shannon is developing engineered costimulatory constructs to improve T cell immunotherapy of leukemia. She is testing means to overcome specific obstacles to immunotherapy of solid tumors, using in vivo and in vitro models of lung cancer.


file

Leah Schmidt, PhD

Postdoctoral Research Fellow


Leah is a new fellow who will be using autochthonous mouse models of cancer to test strategies for improving the efficacy of adoptive immunotherapies.


file

Natalie Duerkopp

Project Manager
file

Breanna Bates

Research Technician
file

Patrick Bonson

Research Technician
file

Jennifer Cao

Research Technician
file

Edison Chu

Research Technician
file

Andrew Daman

Research Technician
file

Nicolas Garcia

Research Technician
file

Jennifer Hotes

Research Technician
file

Ayaka Hulbert

Research Technician
file

Lara Kropp

Research Technician
file

Xiaoxia (Sasha) Tan

Research Technician
file

Kumiko Tsubota

Research Technician